Comparison of Efficacy and Safety of Different Therapeutic Regimens as 
Second-line Treatment for Small Cell Lung Cancer

Comparison of Efficacy and Safety of Different Therapeutic Regimens as 
Second-line Treatment for Small Cell Lung Cancer

Background and objective Small-cell lung cancer (SCLC) is an aggressive disease for which the mainstay of treatment is cytotoxic chemotherapy. Despite good initial responses most patients will relapse or progress after the first-line therapy. The evidence of a benefit from second-line chemotherapy i...

Full description

Bibliographic Details
Main Authors: Zhihua LI, Xiaoqing LIU, Jianjie LI, Hongjun GAO, Chuanhao TANG, Xiaoyan LI, Wanfeng GUO, Haifeng QIN, Weixia WANG, Lili QU, Jian CHEN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-05-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Second-line chemotherapy
Response Rate
Survival
Safety
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.05.05

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2015.05.05

Similar Items